A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
Buggage RR, Levy-Clarke G, Sen HN, Ursea R, Srivastava SK, Suhler EB, Altemare C, Velez G, Ragheb J, Chan CC, Nussenblatt RB, Bamji AT, Sran P, Waldmann T, Thompson DJ.
Buggage RR, et al.
Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):63-70. doi: 10.1080/09273940701299370.
Ocul Immunol Inflamm. 2007.
PMID: 17558830
Free PMC article.
Clinical Trial.